首页 正文

FGFR2 amplification and fusion identified by NGS align with FGFR2b overexpression

{{output}}
FGFR2b is an emerging therapeutic target in HER2-negative advanced gastric cancer (AGC). However, diagnostic concordance between FGFR2b immunohistochemistry (IHC) and genomic assays has been inconsistent due to tumor heterogeneity. The clinical relevance of FG... ...